Using high-throughput single-cell B-cell receptor sequencing (scBCR-seq) we obtained accurately paired full-length heavy-and light-chain variable domains from thousands of individual B cells in a massively parallel fashion. We sequenced more than 250,000 B cells from rat, mouse and human repertoires to characterize their lineages and expansion. In addition, we immunized rats with chicken ovalbumin and profiled antigen-reactive B cells from lymph nodes of immunized animals. The scBCR-seq data recovered 81% (n = 56/69) of B-cell lineages identified from hybridomas generated from the same set of B cells that were subjected to scBCR-seq. Importantly, scBCR-seq identified an additional 710 candidate lineages that were not recovered as hybridomas. We synthesized, expressed and tested 93 clones from the identified lineages and found that 99% (n = 92/93) of the clones were antigen-reactive. Our results establish scBCR-seq as a powerful tool for antibody discovery.
INTRODUCTION
Antibody diversity is an important feature of the adaptive immune system. B cells produce a diverse array of antibodies by rearranging variable (V), diversity (D) and joining (J) immunoglobulin (Ig) germline gene segments [1] [2] [3] . Somatic hypermutation and class switching add to antibody diversity. A mature antibody consists of two identical heavy chains linked through disulphide bonds and two identical light chains each linked to one of the heavy chains, generating two identical antigen binding sites formed by the first immunoglobulin domain of each chain combined 2 . The heavy and light chains are encoded in separate gene loci and each B cell normally expresses a single functional heavy and light chain sequence.
Next-generation sequencing (NGS) has been applied to understand the diversity of the variable regions of heavy (VH) and light chains (VL) that determine the antigen specificity of the antibodies. Until recently, the majority of high-throughput sequencing approaches produced unpaired VH and VL repertoires, as generating paired information requires obtaining data at the individual cell level 4 . Recently, techniques using fabricated microfluidic devices or axisymmetric flow-focusing devices and water-in-oil emulsions have demonstrated the potential for obtaining VH-VL pairing information in a high-throughput manner [5] [6] [7] . However, limitations in sequencing technologies allow only partial variable region sequences to be obtained using these methods, and clonal size information is partially lost. High-throughput techniques that yield full-length variable region sequence information from individual B cells would enable routine application of large-scale immune repertoire sequencing to antibody discovery and detailed repertoire characterization.
Here we describe the application of high-throughput single-cell sequencing to obtain the VH and VL sequences for antibodies from individual human, rat and mouse B cells. We developed a bioinformatics framework to analyze the sequence data and identify accurate VH and VL pairing. Further, we show the utility of the technique for antibody discovery by expressing and testing predicted antigen-reactive antibody sequences. We demonstrate the potential of direct sequencing of individual antigen-reactive B cells to rapidly generate a large and diverse panel of antigen-specific antibody variable regions and thus expand immune repertoire sampling and expedite antibody discovery processes.
RESULTS

Massively parallel sequencing of B-cell receptors from individual cells
We analyzed >250,000 individual IgG pos B cells from three human donors and two mice, and IgM neg B cells from two rats using emulsion-based encapsulation, cDNA generation and sequencing. Briefly, we generated 5' barcoded cDNA from thousands of individual B cells in parallel, and amplified the VH and VL regions using custom primers while retaining the cell barcode ( Fig. 1, Supplementary Fig. 1-2 , and Methods). The 5' barcoded VH and VL domainencoding cDNAs were sheared and converted into sequencing-ready libraries by addition of appropriate adapter oligonucleotides ( Supplementary Fig. 1 ). The library construction method involves 3' cDNA shearing after amplification to create a set of fragments with variable 3' end, while retaining the 5' end for all fragments. This resulted in sequencing reads with constant 5' sequence and variable 3' sequence, allowing de novo assembly of full-length VH and VL sequences from short-read data (2 x 150 bp). We devised a computational pipeline for cell detection, de novo contig assembly, variable domain annotation, and pairing of full-length VH and VL sequences ( Fig. 2a, Supplementary Fig. 3 ). Assembled VH and VL sequences were parsed for framework and complementarity-determining regions (CDR) and filtered for open reading frames encoding the entire variable regions. As expected, read coverage was highest at the constant 5' end and more variable at the 3' end ( Fig. 2b, Supplementary Fig. 4 ). For this reason, we only considered the first 4 codons of the framework 4 region, ensuring that a minimum of 4 codons match germline sequences without frameshifts immediately following the third CDR in both chains (CDR-H3 and L3), providing enough sequence information to determine CDR-H3 and L3 boundaries with high confidence. The median number of reads supporting assembled contigs was at least 175, 213, and 55 throughout the CDR-L3 region, and at least 3, 6, and 11 throughout the CDR-H3 region for rat, mouse and human B-cell repertoires, respectively ( Fig. 2b, Supplementary Fig. 4 ). Cells with complete VH and VL domains were filtered by requiring a minimum number of reads (10 and 100 for VH and VL, respectively) and requiring one dominant VH and VL contig (≥ 80% read support; Fig. 2c , Supplementary Fig. 5 ).
Pairing efficiency, defined as the percentage of cells with at least one detected VH and VL, was 48-94%, depending on sample type, and 48-74% of cells with pairing information passed quality filters ( Fig. 2d ). Variation in pairing and filtering efficiency may be due, in part, to differences in heavy-and light-chain transcript levels, primer efficiency and primer coverage.
Overall, a total of 261,539 sequenced B cells yielded high-quality VH-VL pairing information for 116,115 cells from rat (n = 30,380), mouse (n = 9,459) and human (n = 76,276) B-cell repertoires ( Fig. 2d , Supplementary Fig. 3 , Supplementary Tables 1-11 ).
VH-VL pairing accuracy
To assess the accuracy of assembled VH and VL sequences and VH-VL pairing, we used hybridomas obtained after immunizing rats with chicken ovalbumin as a test sample. We analyzed individual clones by a standard sequencing approach to obtain a reference set of paired VH-VL sequences for 127 unique clones (see Methods). Clones were pooled, grown in culture, and subjected to scBCR-seq. scBCR-seq yielded high-quality VH-VL sequence pairs for 1,989 cells, representing 120 unique VH-VL sequence pairs. More than 90% of cells (1,801/1,989) showed a perfect match with one of the reference VH-VL pairs and more than 99% (1,972/1,989) matched one of the reference VH-VL pairs when allowing for up to two nucleotide mismatches ( Fig. 3a ).
Next, we assessed VH-VL pairing accuracy based on B-cell repertoire data sets from human, mouse and rat samples. Cells within the same B-cell lineage are expected to have light chains with concordant light-chain germline V gene (VL) in the majority of cases 8 . We assumed cells with identical heavy-chain V germline (VH) gene and CDR-H3 belonged to clonally related B cells, and calculated the percentage of cells with concordant paired VL germline. Concordance in the subset of lineages with more than one B cell was 98% for human (based on 754-2,131 cells in 351-894 lineages), 96% for mouse (445 and 979 cells in 148 and 225 lineages, respectively), and 93% for rat data sets (209 and 598 cells in 97 and 269 lineages, respectively) ( Fig. 3b ). These estimates are likely lower bounds for pairing accuracy, due to coincidental VH and CDR-H3 matches in some B-cell lineages, in particular for short CDR-H3 sequences more prevalent in rodents 9 .
Rat and mouse B-cell repertoires
We profiled IgM neg B-cell repertoires from two non-immunized rats (n = 30,380) and
IgG pos B-cell repertoires from two mice (n = 9,459) ( Fig. 2d , Supplementary Fig. 6a,b ). Data at single-cell resolution allowed us to characterize unique B-cell lineages and quantify their expansion based on the number of cells observed for each lineage. We defined B-cell lineages by grouping cells with identical VH and VL germline genes and requiring at least 80% nucleotide identity in the CDR-H3 region. For the two rat samples, only 7% (1,081/15,338) and 3% (431/15,042) of cells belonged to clonally expanded lineages ( Supplementary Fig. 7 ). For the two mouse samples, 13% (699/5,448) and 34% (1,353/4,011) of cells belonged to clonally expanded lineages, suggesting some level of antigenic stimulation in these mice ( Supplementary Fig. 7 ). We asked whether the identified B-cell lineages showed preferential usage of particular VH genes, VL genes or VH-VL gene pairings. We observed that some germline gene segments were consistently used more frequently than others across replicates ( Fig. 4 ).
This was particularly noticeable for mouse VH and VL genes (r = 0.89, r = 0.84, Spearman correlation coefficient) and to a lesser extent for rat VH genes (r = 0.52) ( Supplementary Fig. 8 ).
For example, IGHV3-2 was the most commonly used mouse VH gene in both animals, present in 6.2% and 4.4% of lineages, respectively. After correcting for variation in VH and VL gene usage, some individual VH-VL gene pairings showed higher than expected frequencies across replicates ( Supplementary Fig. 8 ). For example, both mouse samples showed increased frequencies for IGHV8-12:IGKV3-7 (9 and 7 lineages) and IGHV3-2:IGKV5-43 (45 and 16 lineages). Higher than expected pairings may be due to immune responses to common antigens. Consistent with this interpretation, several of the IGHV8-12:IGKV3-7 lineages showed evidence for expansion in both animals (3/9 and 5/7 lineages, respectively).
Human B-cell repertoires
Next, we analyzed human IgG pos B-cell repertoires from three donors, each profiled at two different time points (n = 76,276) ( Fig. 2d , Supplementary Fig. 6c ). All samples showed evidence for lineage expansion, with 14-26% of cells belonging to expanded lineages ( Supplementary Fig. 7 ). VH and VL gene usage was highly reproducible between replicates from the same individual (r > 0.98, Supplementary Fig. 9 ). Overall VH and VL gene usage was similar among donors (r > 0.65 and r > 0.87 for VH and VL, respectively, Supplementary Fig. 9 ) and in general agreement with the known distribution of germline usage in human repertoires 10, 11 . Some donors lacked antibodies for a subset of germline gene segments (e.g. IGHV3-9 in Donor 1 or IGHV4-38-2 in Donor 2), most likely due to genotype differences in the germline repertoires 11 . Interestingly all samples showed higher than expected pairing frequencies for IGHV3-7:IGKV2-30 (19-62 lineages per sample) ( Fig. 5 , Supplementary Fig. 9 ). To rule out a technical artifact due to the profiling method, we reanalyzed published VH-VL pairing information for naïve and antigen-experienced human B cells that were obtained by overlap extension RT-PCR and independent computational methods 12 . Interestingly, the published data showed strongest enrichment for IGHV3-7:IGKV2-30 among all V germline gene pairings for antigen-experienced, but not naïve B cells, suggesting this pairing may be the result of stereotypical immune responses ( Supplementary Fig. 10 ).
Single-cell sequencing enables rapid discovery of antigen-reactive antibodies
To assess the potential of scBCR-seq for antibody discovery, we immunized rats with chicken ovalbumin (OVA) and subjected IgM neg /OVA pos lymph node B cells from three immunized animals to scBCR-seq ( Supplementary Fig. 6d ). After quality filtering we obtained VH-VL pairing information for 3,091 B cells ( Supplementary Table 12 ). As expected, significant clonal expansion was inferred in this dataset with 88% of cells belonging to clonally expanded lineages ( Fig. 6a ). Of 766 unique B-cell lineages, 288 (38%) were represented by three or more individual B cells. By contrast, IgM neg B cells from naïve rats showed limited evidence for clonal expansions (Fig. 6b ). Chain pairing accuracy assessed by light-chain germline concordance was 99%, consistent with results obtained for naïve rats. Somatic mutation load in the VH and VLderived regions (i.e. excluding CDR-H3 and J regions in both chains) was higher in anti-OVA cells than in IgM neg B cells from naïve rats ( Fig. 6c ). In addition to directly sequencing B cells from OVA-immunized animals, we also generated and sequenced OVA-specific hybridomas derived from a fraction of the IgM neg B cells from the same rats. In this data set we identified 69 unique B-cell lineages, 56 of which were shared with those identified by direct B-cell scBCR-seq ( Fig.   6d ). Thus scBCR-seq recovered 81% (56/69) of anti-OVA lineages from the hybridoma experiment, and identified an additional 710 candidate lineages.
scBCR-seq identifies multiple antigen-reactive antibodies
We selected a set of 96 BCR (VH-VL) pairs identified from the OVA pos B-cell scBCR-seq data for functional analysis. We selected the BCR sequence pairs from a range of lineage sizes observed in the scBCR-seq data ( Supplementary Table 13 ). A random B-cell clone was selected from lineages represented by 3 or more individual B cells. For lineages with 1-2 cells, which may be enriched for antigen-negative clones due to imperfect cell sorting, we prioritized clones with high read count based on the assumption that these may be antibody-secreting cells induced by an active immune response. Of the 96 selected BCR sequence pairs, 77 were from lineages with three or more cells and 19 were from lineages with 1-2 cells. Of the 96 selected clones, 93 were from lineages not found in the hybridoma panel and 3 had non-identical but clonally related OVA-specific monoclonal antibodies. Synthesized VH and VL DNA sequences were cloned into human IgG1/k expression vectors and rat/human chimeric IgG was expressed in mammalian cells (see Methods). We found that 93 of the 96 clones showed robust protein expression with a median yield of 85 µg of purified IgG per ml of culture ( Supplementary Table   13 ). All but 4 of the 93 clones (96%) specifically bound OVA in an enzyme-linked immunosorbent assay (ELISA) ( Supplementary Fig. 11a ). To assess the importance of correct chain pairing for antigen binding in this panel, we shuffled each of the heavy and light chain expression constructs with a non-cognate chain to generate 96 additional antibodies with nonnative light and heavy chain pairs. Eighty-six of the 96 shuffled clones expressed as IgG and only 5 of these showed OVA reactivity ( Supplementary Fig. 11b ), confirming the relevance of accurate chain pairing for identification of antigen-binding antibodies. We further determined the affinity of the 93 expressed antibodies for OVA by surface plasmon resonance (SPR).
Eighty-nine clones, including 3 clones with weak binding in ELISA, bound to OVA in SPR, with monovalent equilibrium dissociation constants ranging from the limit of detection (10 pM) to 30 nM ( Fig. 6e , Supplementary Fig. 11 , Supplementary Table 13 ). Interestingly, binding affinity did not correlate with lineage size or read counts per cell ( Supplementary Table 13 ). Overall, 86 of the 93 expressed antibodies (92%) bound OVA in both ELISA and SPR, and 92 antibodies (99%) bound OVA in one of the two assays. These findings show scBCR-seq to be a robust tool for rapid discovery of a large panel of antigen-reactive antibodies.
DISCUSSION
Antibody discovery methods based on molecular cloning of antibody repertoires are limited by the inability to easily process large numbers of single cells in parallel. Nextgeneration sequencing technologies that capture paired antibody heavy-and light-chain information have been described but require custom equipment and do not yield full-length variable region sequences or true single-cell sequence information. We show that scBCR-seq yields full-length antibody variable region sequences from a variety of species at an individual cell level. While framework region 4 sequences were partially truncated, the short missing regions, unlike CDR regions directly involved in antigen binding, can be easily reconstructed from germline sequences with minimal impact on antigen binding properties. Importantly, scBCR-seq does not require a complex set of primers covering the highly diverse VH and VL germlines of human and rodent repertoires and somatic mutations, minimizing biases and blind spots introduced in the amplification process. Thus scBCR-seq should be applicable with minimal modification to other species, including those for which only constant region sequences are known.
Our results show that scBCR-seq can be used for rapid discovery of large, diverse panels of high-affinity antigen-specific antibodies with natively paired heavy-and light-chains when combined with high-quality antigen-specific B cells sorting. This is supported by the high rate of antigen binders and the high overlap between the anti-OVA B-cell repertoire and hybridoma sequencing. The highly consistent VL germline pairing with clonally related heavy chains support the high quality of chain pairing information yielded. Here we only tested a subset of the diversity yielded by scBCR-seq. We expect that more in-depth analyses of clones within expanded antigen-specific B-cell lineages will allow easy and rapid identification of higher affinity variants within each lineage. In addition, the availability of datasets with thousands of paired-chain, full-length variable region sequences from individual antigen-specific B cells will allow detailed large-scale characterization of the dynamics of immune responses, and the functional impact of germline usage, clonal expansion and somatic mutation on antibody repertoires.
ACKNOWLEDGMENTS
We thank the Genentech NGS Lab for their support during the course of this project. We also thank Qing Zhang for her support during the development of the Absolve annotation pipeline. 
AUTHOR CONTRIBUTIONS
Conceptualization
COMPETING INTERESTS
The authors are employees of Genentech or SciGenom Labs. Genentech authors hold shares in Roche. Supplementary Fig. 12 ).
METHODS
Isolation of IgG pos B cells from human blood
Preparation of naïve Balb/c mouse and rat lymph node (LN) B cells
All animals used in this study were housed and maintained at Genentech in accordance with and BV510 anti rat CD4 (Clone OX35, BD Bioscience, San Jose, CA)) and sorted for B cells (100,000 cells) on a FACSAria II cell sorter ( Supplementary Fig. 14) .
Immunization of rats and antigen-specific cell sorting
Three SD rats (Charles River, Hollister, CA) were immunized with 100 µg OVA (Sigma-Aldrich, St. 
Cell count estimate
For each library we tallied the number of reads for expected cell barcode sequences. Barcodes from cell-containing droplets were identified as those with read count exceeding a libraryspecific cutoff, defined as 0.1 times the read count for barcodes at rank 150, the 97.5th percentile for 6,000 targeted cells.
Contig assembly
We trimmed the first 39 bases for read 1 covering the 16 nt cell barcode, 10 nt unique molecular identifier (UMI) and 13 nt switch oligo. Barcode and UMI sequences were retained for each read. Reads were demultiplexed based on perfect matches to one of the expected barcode sequences. Subsequent processing was done independently for each barcode. If reads for a given barcode exceeded 100,000, they were downsampled to 100,000. Reads were used as input for de novo assembly with SSAKE (3.8.5) 14 with options '-p 1 -c 1 -w 1 -e 1.5' and expected mean insert size 600. We defined concordant read pairs as those with both reads fully embedded in the assembly and paired in the expected orientation. Contigs without concordant read pairs were discarded. Contigs were trimmed to regions supported by concordant read pairs. In cases with more than one contiguous supported region, the region with highest number of concordant read pairs was selected.
Contig annotation
Sequences were annotated with a custom bioinformatics pipeline for variable domain analysis 
Heavy-and light-chain pairing
Lineage definition
Filtered cells were grouped into lineage clusters. Two cells were grouped together if they had identical germline VH and VL genes, ignoring allele number, identical CDR-H3 length and ≥ 80% identical CDR-H3 sequence. JH and JL genes were ignored for lineage definition due to the lower sequence coverage in this region.
Antibody expression and binding assays
Selected B-cell clones from the OVA immunization dataset were produced by DNA synthesis and cloned in mammalian expression vectors 20 as chimeric human IgG1/kappa antibodies.
Sequences with clearly incorrect FR4 terminal sequences were corrected based on the assigned J germline information for that clone but no additional coding changes were introduced in sequences. Antibodies were transfected into Expi293 cells at 1 ml scale and purified in batch mode by protein A chromatography 21, 22 . Antibodies with mispaired chains were made by combining each of the 96 heavy chain clones with a light chain clone from a different anti-OVA antibody. Purified IgGs were tested for binding to OVA in ELISA and in an SPR assay using a BIAcore T200 apparatus (GE Life Sciences, Piscataway, NJ) in a protein A capture format. Soluble monomeric OVA was the analyte in SPR, using the single cycle kinetics method at 25°C.
Data availability
Raw sequence data generated during the current study will be made available in the Gene Expression Omnibus (GEO) repository before publication.
Code availability
The custom bioinformatics pipeline for variable domain analysis is available under the MIT License on GitHub (https://github.com/Genentech/Absolve).
FIGURES
Figure 1
Schematic of single B cell capture, library construction and sequencing. Chromium controller (10x Genomics, Pleasanton, CA) was used to capture single cells along with gel beads containing the 5' switch oligo with cell barcode, reverse transcriptase and poly(dT) primer. The barcoded cDNAs were then converted into a library and sequenced (Illumina, San Diego, CA). Heavy-and light-chain sequences for individual cells were analyzed using a custom computational pipeline. 
SUPPLEMENTARY FIGURES
Supplementary Figure 1
Schematic of single-cell cDNA generation and library construction following the manufacturer's user guide (10x Genomics, Pleasanton, CA, CG000086_SingleCellVDJReagentKitsUserGuide_RevB). Only heavy chain is shown. 
Supplementary Figure 2
Supplementary Figure 4
Read coverage for assembled VH and VL contigs. Otherwise as in Fig. 2b .
Supplementary Figure 5
Cell quality filtering. Otherwise as in Fig. 2c .
Supplementary Figure 6
Representative B cell sorting gates for naïve mice (a), naïve rat (b), human (c) and pooled OVAimmunized rats (d).
Supplementary Figure 7
Lineage expansions. Otherwise as in Fig. 6a,b .
Supplementary Figure 8
Pairwise scatter plots of VH frequencies (left), VL frequencies (center), and standardized residuals for VH-VL pairings frequencies (right) for two rats (top) and two mice (bottom).
Frequencies indicate the percentage of lineages with a particular germline gene segment.
IGHV8-12:IGKV3-7 and IGHV3-2:IGKV5-43 are highlighted in red.
Supplementary Figure 9
Pairwise scatter plots of VH frequencies (left), VL frequencies (center), and standardized residuals for VH-VL pairing frequencies (right) for three human donors profiled in duplicate.
Frequencies indicate the percentage of lineages with a particular germline gene segment. IGHV3-7:IGKV2-30 is highlighted in red. 
Supplementary Figure 10
Supplementary Figure 11
ELISA results for predicted OVA antigen-reactive B cell clones (a) and negative controls obtained by mispairing VH and VL chains (b). Clones are ranked by OVA ELISA signal separately in (a) and (b). 
Supplementary Figure 12
Supplementary Figure 13
Naïve Balb/c mouse B cell sort gating strategy. 1) FSC vs SSC to gate lymphocytes, 2/3) SSC-H/SSC-W, FSC-H/FSC-W gates to exclude cell doublets, 4) FSC/PI for dead cell exclusion (PInegative gate), 5) IgG FITC/B220-APC to sort for IgG pos B cells. IGKV1U10  IGKV1S14  IGKV1S21  IGKV1S22  IGKV1U75  IGKV2U3  IGKV2U17  IGKV2S23  IGKV2S26  IGKV3S1  IGKV3S8  IGKV3S9  IGKV3S10  IGKV3S11  IGKV3S18  IGKV3S19  IGKV5S12  IGKV6S5  IGKV6S8  IGKV6S10  IGKV6S11  IGKV8S4  IGKV8S5  IGKV8S6  IGKV10S5  IGKV10S9  IGKV12S16  IGKV12S26  IGKV12S29  IGKV12S30  IGKV12U30  IGKV12S31  IGKV12S32  IGKV12S34  IGKV12S36  IGKV12S38  IGKV12S39  IGKV12U74  IGKV14S9  IGKV14S18  IGKV15S2  IGKV16S1  IGKV16U47  IGKV17S1  IGKV19S2  IGKV22S2  IGKV22S4  IGKV22S6  IGKV22S7  IGKV22U26  IGKV22U53   IGHV11 IGKV1U10  IGKV1S14  IGKV1S21  IGKV1S22  IGKV1U75  IGKV2U3  IGKV2U17  IGKV2S23  IGKV2S26  IGKV3S1  IGKV3S8  IGKV3S9  IGKV3S10  IGKV3S11  IGKV3S18  IGKV3S19  IGKV5S12  IGKV6S5  IGKV6S8  IGKV6S10  IGKV6S11  IGKV8S4  IGKV8S5  IGKV8S6  IGKV10S5  IGKV10S9  IGKV12S16  IGKV12S26  IGKV12S29  IGKV12S30  IGKV12U30  IGKV12S31  IGKV12S32  IGKV12S34  IGKV12S36  IGKV12S38  IGKV12S39  IGKV12U74  IGKV14S9  IGKV14S18  IGKV15S2  IGKV16S1  IGKV16U47  IGKV17S1  IGKV19S2  IGKV22S2  IGKV22S4  IGKV22S6  IGKV22S7  IGKV22U26  IGKV22U53 0 > 1% 
Supplementary Figure 14
Figure 4
